2021
DOI: 10.3390/molecules26216723
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoids—Characteristics and Potential for Use in Food Production

Abstract: Scientific demonstrations of the beneficial effects of non-psychoactive cannabinoids on the human body have increased the interest in foods containing hemp components. This review systematizes the latest discoveries relating to the characteristics of cannabinoids from Cannabis sativa L. var. sativa, it also presents a characterization of the mentioned plant. In this review, we present data on the opportunities and limitations of cannabinoids in food production. This article systematizes the data on the legal a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
36
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(37 citation statements)
references
References 142 publications
1
36
0
Order By: Relevance
“…Protein Data Bank ( , accessed on 16 March 2022) provided the three-dimensional crystal structures of the SARS-CoV-2-RBD (PDB ID: 6M17) complex and SARS-CoV-RBD (PDB ID:3R4D) with 2.9 Å and 3.1 Å resolution, respectively [ 5 , 28 ]. To identify cannabinoids of the potential antiviral activities, we obtained bioactive molecules of cannabis from PubMed ( , accessed on 18 March 2022) and traditional Chinese medicine system pharmacology (TCMSP) ( , accessed on 18 March 2022) as well as other reports with 2D structures in SDF file format [ 29 , 30 , 31 , 32 ]. We obtain a total of 42 non-repeat bioactive compounds to use as ligands for further investigation.…”
Section: Methodsmentioning
confidence: 99%
“…Protein Data Bank ( , accessed on 16 March 2022) provided the three-dimensional crystal structures of the SARS-CoV-2-RBD (PDB ID: 6M17) complex and SARS-CoV-RBD (PDB ID:3R4D) with 2.9 Å and 3.1 Å resolution, respectively [ 5 , 28 ]. To identify cannabinoids of the potential antiviral activities, we obtained bioactive molecules of cannabis from PubMed ( , accessed on 18 March 2022) and traditional Chinese medicine system pharmacology (TCMSP) ( , accessed on 18 March 2022) as well as other reports with 2D structures in SDF file format [ 29 , 30 , 31 , 32 ]. We obtain a total of 42 non-repeat bioactive compounds to use as ligands for further investigation.…”
Section: Methodsmentioning
confidence: 99%
“…Some of these cannabinoids may be used to treat human ailments such as pain, anxiety and cachexia [ 34 , 36 ], to stimulate appetite, and to act as an antiemetic [ 37 ]. The primary metabolites (amino acids, fatty acids, and steroids) in low-THC hemp plants are used to synthesize secondary metabolites such as flavonoids, terpenoids, lignans, alkaloids and phytocannabinoids [ 38 ], the latter being characterized by a C21 terpenophenolic backbone [ 18 , 33 ]. The synthesis of THC involves the decarboxylation of delta-9-tetrahydrocannabinolic acid (THCA); whereas CBD is a decarboxylated product of cannabidiolic acid (CBDA) [ 39 ].…”
Section: Distribution Of Nutrients and Phytocannabinoids In Low-thc ...mentioning
confidence: 99%
“…However, the permitted amount of CBD per serving should not exceed 20 mg and the sales pack may not exceed a total of 600 mg of CBD [ 3 ] and should contain less than 0.001% THC [ 80 ]; whereas, in the USA, edibles should contain less than 0.3% THC and CBD at levels between 10 and 1500 mg [ 81 ]. Despite these regulations, there are concerns about some errors in labelling where the cannabinoid concentration of the edibles does not correspond with the content recorded on the labels [ 38 ]. Some edibles have been found to contain either less or more cannabinoid content than the amount claimed on the label [ 82 ].…”
Section: Cannabis Ediblesmentioning
confidence: 99%
“…However, marketing challenges and differently regulated hemp‐based supplements in various countries are among other challenges to the applications of hemp‐derived phytochemicals and hemp extracts in food and pharmaceutical products (Cohen & Sharfstein, 2019). In addition, more data on the cannabinoid stability in different food matrices and storage processes are warranted to augment the commercial popularity and utilise the great potential of hemp food and supplements (Kanabus et al ., 2021).…”
Section: Introductionmentioning
confidence: 99%